In our previous research, CPT1A had been identified to be differentially expressed with significance in paclitaxel-resistant ovarian cancer cell line A2780, and inhibition of CPT1A resulted in a prominent decrease of paclitaxel-resistant phenotype (14). The gene discussed is CPT1A; the disease is ovarian carcinoma.